MIF degrader MD13 - CAS 2758431-97-7

MIF degrader MD13 is involved in protein-protein interactions that play key roles in inflammation and cancer. Current strategies to develop small molecule modulators of MIF functions are mainly restricted to the MIF tautomerase active siteMIF degrader MD13. MD13 also exhibits antiproliferative effect in a 3D tumor spheroid model. In conclusion, we describe the first MIF-directed PROTAC (MD13) as a research tool, which also demonstrates the potential of PROTACs in cancer therapy.

PROTACs, Others, MIF

PROTAC, Immunology/Inflammation, Others

2758327

C35H35N5O8

653.68

O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=CC2NCCCCCCCC(NC4=CC=C(C=C4)N5CC=6C(OC5=O)=CC(O)=CC6)=O

-20°C

Ice Packs

PROTAC